WINTON GROUP Ltd Cuts Stake in HCA Healthcare, Inc. $HCA

Key Points

• WINTON GROUP Ltd cut its HCA Healthcare stake by 84.2% in the second quarter, selling 6,203 shares and retaining 1,160 shares valued at approximately $452,000. Institutional investors collectively own 62.73% of HCA.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $462.64 versus HCA’s reported opening price of $423.13.
• HCA exceeded quarterly expectations with earnings of $7.59 per share and revenue of $20.23 billion, up 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, representing a 0.7% annualized yield.

WINTON GROUP Ltd trimmed its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 84.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,160 shares of the company's stock after selling 6,203 shares during the quarter. WINTON GROUP Ltd's holdings in HCA Healthcare were worth $452,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of HCA. MidFirst Bank purchased a new stake in HCA Healthcare during the 2nd quarter worth $28,000. Clearstead Trust LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at about $29,000. Cedar Mountain Advisors LLC acquired a new position in HCA Healthcare during the 1st quarter worth approximately $33,000. MCF Advisors LLC grew its position in HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company's stock valued at $34,000 after acquiring an additional 49 shares in the last quarter. Finally, Basepoint Wealth LLC purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $35,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have commented on HCA shares. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 7th. KeyCorp cut their price target on HCA Healthcare from $475.00 to $435.00 and set an "overweight" rating on the stock in a research note on Monday, July 27th. Wells Fargo & Company upped their target price on HCA Healthcare from $369.00 to $381.00 and gave the company an "equal weight" rating in a research report on Monday, August 3rd. Mizuho decreased their price target on shares of HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating for the company in a research report on Tuesday, July 28th. Finally, Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $462.64.

HCA Healthcare Trading Down 0.6%

Shares of NYSE HCA opened at $423.13 on Wednesday. The company has a market capitalization of $91.61 billion, a price-to-earnings ratio of 14.17, a price-to-earnings-growth ratio of 1.40 and a beta of 1.10. The business has a 50 day simple moving average of $405.17 and a 200-day simple moving average of $431.16. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion for the quarter, compared to analysts' expectations of $19.76 billion. During the same period in the prior year, the company earned $6.84 earnings per share. The firm's revenue was up 8.7% compared to the same quarter last year. As a group, equities analysts predict that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's dividend payout ratio is presently 10.45%.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Higher BofA price target: Bank of America raised its price target for HCA Healthcare to $450 from $425, signaling improved confidence in the company’s outlook and potential upside. BofA Adjusts Price Target on HCA Healthcare
• Positive Sentiment: CHCP acquisition completed: HCA Healthcare finalized its purchase of The College of Health Care Professions, expanding its healthcare-education platform. The company said the transaction should help develop additional nurses and other healthcare professionals, potentially supporting long-term staffing needs across its network. HCA Healthcare Completes Acquisition of the College of Health Care Professions
• Positive Sentiment: Hospital investment: HCA plans to invest more than $32 million in Mission Health facilities across western North Carolina. The spending could improve capacity, equipment and service offerings, although the financial return is likely to develop over time. HCA Healthcare invests $32M in Mission Health hospitals
• Neutral Sentiment: Technology rollout advances: MEDITECH Expanse electronic health records are now live across 34 HCA hospitals in the Capital and North Florida divisions. The implementation may improve workflow and data coordination, but it also represents an ongoing execution and integration effort. MEDITECH Expanse EHR Live Across HCA Healthcare
• Neutral Sentiment: Leadership updates: HCA-affiliated hospitals in California and Idaho appointed new chief executive officers. The moves may support local operations, but they are unlikely to materially affect near-term earnings. HCA California hospital names CEO
• Negative Sentiment: Shareholder investigation: Pomerantz LLP announced an investigation into potential claims on behalf of HCA investors. The announcement does not establish wrongdoing, but the prospect of litigation or regulatory concerns creates headline and legal-risk overhang for the stock. Pomerantz Investor Alert on HCA Healthcare

HCA Healthcare Profile

HCA Healthcare, Inc NYSE: HCA is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.